🇺🇸 Metformin + Rosuvastatin in United States

2 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 2

Most-reported reactions

1. Blood Glucose Fluctuation — 1 report (50%)
2. Blood Glucose Increased — 1 report (50%)

Source database →

Frequently asked questions

Is Metformin + Rosuvastatin approved in United States?

Metformin + Rosuvastatin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Metformin + Rosuvastatin in United States?

Jeil Pharmaceutical Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.